[1]中国医疗器械行业协会体外诊断分会. 中国体外诊断行业年度报告[R]. 2017.
[2]杨晓月, 陈枢青. 精准医疗计划[J]. 中国生化药物杂志, 2016,36(7): 8-11.
Yang X Y, Chen S Q. Precision medicine plan[J]. Chinese Journal of Biochemical Pharmaceutics, 2016,36(7): 8-11.
[3]Ding L, Getz G, Wheeler D A, et al. Somatic mutations affect key pathways in lung adenocarcinoma[J]. Nature, 2008, 455(7216): 1069-1075.
[4]Veronesi A, Giacomi C, Magri M D, et al. Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases[J]. BMC Cancer, 2005, 5(1): 1-6.
[5]Krishnamurti U, Silverman J F. HER2 in breast cancer: a review and update[J]. Advances in Anatomic Pathology, 2014, 21(2), 100-107.
[6]Kline M C, Duewer D L, Travis J C, et al. Production and certification of NIST Standard Reference Material 2372 Human DNA Quantitation Standard[J]. Analytical and Bioanalytical Chemistry, 2009, 394(4): 1183-1192.
[7]He H J, Almeida J L, Lund S P, et al. Development of NIST standard reference material 2373: Genomic DNA standards for HER2 measurements[J]. Biomolecular Detectction and Quantification, 2016, 8: 1-8.
[8]World health Organization. Collabrative study to evaluate the proposed WHO 1st international reference panel for genomic JAK2 V617F: WHO/BS/2016. 2293[R]. 2016.
[9]Gregory J T, Jason D P, Francine B A, et al. Routine use of the ion torrent AmpliSeqTM cancer hotspot panel for identification of clinically actionable somatic mutations[J]. Clinical Chemistry and Laboratory Medicine, 2014, 52(5): 704-714.
[10]YY/T 1182-2010 核酸扩增检测用试剂(盒)[S]. 2010.
[11]高运华, 李海峰, 李建新, 等. 荧光标记DNA高分辨电感耦合等离子体质谱定量分析[J]. 高等学校化学学报, 2010, 31(12): 002360-2365.
Gao Y H, Li H F, Li J X, et al. Quantitative Analysis of Fluorescent Dye-labeled DNA by High Resolution Inductively Coupled Plasma Mass Spectrometry[J]. Chemical Journal of Chinese Universities, 2010, 31(12): 2360-2365.
[12]Hayden R T, Gu Z, Ingersoll J, et al. Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus[J]. Journal of Clinical Microbiology, 2013, 51(2): 540-546.
[13]Quan P L, Sauzade M, Brouzes E. dPCR: A Technology Review[J]. Sensors (Basel), 2018, 18(4):1271.
[14]Mollinari M, Serang O. Plant Genotyping[M]. New York: SpringerLink: Humana Press, 2015: 215-241.
[15]Ponti G, Maccaferri M, Manfredini M, et al. The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients[J]. Clinica Chimica Acta; International Journal of Clinical Chemistry, 2018, 479(6): 14-19.
[16]Eklund A C, Szallasi Z. Correction of technical bias in clinical microarray data improves concordance with known biological information[J]. Genome Biology, 2008, 9(2): R26.
[17]Portier B P, Rashmi K S, Rajyalakshmi L, et al. Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencing[J]. American Journal Clinical Pathology, 2014, 141: 559-572.
[18]董莲华, 王晶, 傅博强, 等. 数字PCR和下一代测序方法用于KRAS基因突变检测中的可比性研究[J]. 计量学报, 2018, 39(3): 436-441.
Dong L H, Wang J, Fu B Q, et al. Comparability of Digital PCR and Next Generation Sequencing on Detection of KRAS Mutations Frequency[J]. Acta Metrologica Sinica, 2018, 39(3): 436-441.
[19]Armbruster D A, Pry T. Limit of blank, limit of detection and limit of quantitation[J]. Clinical Biochemistry Reviews, 2008, 29 (S1): 49-52.
[20]Dube S, Qin J, Ramakrishnan R. Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device[J]. PLOS One, 2008, 3(8): e2876.
[21]Wilkinson D E, Baylis S A, Padley D, et al. Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA[J]. International Journal of Cancer, 2010, 126(12): 2969-2983.
[22]Byron S A, Van Keuren-Jensen K R, Engelthaler D M, et al. Translating RNA sequencing into clinical diagnostics: opportunities and challenges[J]. Nature Reviews Genetics, 2016, 17(5): 257-271.
[23]全国标准物质管理委员会. 标准物质定值原则和统计学原理[M]. 北京:中国计量出版社, 2011: 2-5. |